709
Views
104
CrossRef citations to date
0
Altmetric
Review

Xpert® MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

, , , &
Pages 937-946 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Kefyalew N Jaleta, Mucheye Gizachew, Baye Gelaw, Habtie Tesfa, Alem Getaneh & Belete Biadgo. (2017) Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia. Infection and Drug Resistance 10, pages 185-192.
Read now
Mandy LY Sin, Kathleen E Mach, Pak Kin Wong & Joseph C Liao. (2014) Advances and challenges in biosensor-based diagnosis of infectious diseases. Expert Review of Molecular Diagnostics 14:2, pages 225-244.
Read now
Alice Zwerling & David Dowdy. (2013) Economic evaluations of point of care testing strategies for active tuberculosis. Expert Review of Pharmacoeconomics & Outcomes Research 13:3, pages 313-325.
Read now
Pacharee Kantipong, Kuniko Murakami, Saiyud Moolphate, Myo Nyein Aung & Norio Yamada. (2012) Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand. HIV/AIDS - Research and Palliative Care 4, pages 159-168.
Read now
Angelika Niemz & David S Boyle. (2012) Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries. Expert Review of Molecular Diagnostics 12:7, pages 687-701.
Read now
Dmitry Gryadunov, Ekaterina Dementieva, Vladimir Mikhailovich, Tatiana Nasedkina, Alla Rubina, Elena Savvateeva, Eugeny Fesenko, Alexander Chudinov, Danila Zimenkov, Alexander Kolchinsky & Alexander Zasedatelev. (2011) Gel-based microarrays in clinical diagnostics in Russia. Expert Review of Molecular Diagnostics 11:8, pages 839-853.
Read now

Articles from other publishers (98)

Mahmoud M. Tawfick, Mona Shaban E. M. Badawy, Mohammed H. Taleb & Nagwan G. El Menofy. (2023) Tuberculosis Diagnosis and Detection of Drug Resistance: A Comprehensive Updated Review. Journal of Pure and Applied Microbiology.
Crossref
C.D.S. Katoch, Deepu K. Peter, Vikas Marwah, Kunal Kumar & Gaurav Bhati. (2023) Prevalence of isoniazid resistance in cases of rifampicin resistance detected on GeneXpert MTB/RIF assay. Medical Journal Armed Forces India 79, pages S1-S5.
Crossref
Cybele Lara R. Abad & Raymund R. Razonable. (2023) Multi‐drug resistant and rifampin‐resistant tuberculosis in transplant recipients. Transplant Infectious Disease 25:4.
Crossref
Catherine M. Moore, Jasvir Dhillon, Rebecca Flynn, Krzysztof Gizynski, Candice Adams, George Morgan, David McGurk, Eduardo Boada, Shireen Shabestary, Jonathan Peat, Jonathan O'Halloran, Neil G. Stoker, Philip D. Butcher & Heather Murton. (2023) A Novel Microfluidic Dielectrophoresis Technology to Enable Rapid Diagnosis of Mycobacteria tuberculosis in Clinical Samples. The Journal of Molecular Diagnostics 25:7, pages 513-523.
Crossref
Kizil A. Yusoof, Juan Ignacio García, Alyssa Schami, Andreu Garcia-Vilanova, Holden V. Kelley, Shu-Hua Wang, Adrian Rendon, Blanca I. Restrepo, Marcel Yotebieng & Jordi B. Torrelles. (2022) Tuberculosis Phenotypic and Genotypic Drug Susceptibility Testing and Immunodiagnostics: A Review. Frontiers in Immunology 13.
Crossref
Sebsib Selfegna & Amir Alelign. (2022) Detection of Mycobacterium tuberculosis and Rifampicin Resistance Using GeneXpert MTB/RIF Assay at Enat Hospital, Central Ethiopia. Tuberculosis Research and Treatment 2022, pages 1-7.
Crossref
Varagunapandian GurusamyDr.Dr., Sabrena MDr.Dr., A. Affee AsmaDr.Dr., S. SudhishnaaDr.Dr. & Deepika S.R.Dr.Dr.. (2021) ETIOLOGY OF LYMPHADENOPTHY AMONG SOUTH INDIAN POPULTION.. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 53-55.
Crossref
Thaís Zamboni Berra, Dulce Gomes, Antônio Carlos Vieira Ramos, Yan Mathias Alves, Alexandre Tadashi Inomata Bruce, Luiz Henrique Arroyo, Felipe Lima dos Santos, Ludmilla Leideanne Limirio Souza, Juliane de Almeida Crispim & Ricardo Alexandre Arcêncio. (2021) Effectiveness and trend forecasting of tuberculosis diagnosis after the introduction of GeneXpert in a city in south-eastern Brazil. PLOS ONE 16:5, pages e0252375.
Crossref
Nicola Foster, Lucy Cunnama, Kerrigan McCarthy, Lebogang Ramma, Mariana Siapka, Edina Sinanovic, Gavin Churchyard, Katherine Fielding, Alison D. Grant & Susan Cleary. (2021) Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis. PLOS ONE 16:5, pages e0251547.
Crossref
Hong-Chao Liu, Yu-Lu Gao, Dan-Feng Li, Xi-Yi Zhao, Yuan-Qing Pan & Chang-Tai Zhu. (2021) Value of Xpert MTB/RIF Using Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Tuberculosis: a Systematic Review and Meta-analysis. Journal of Clinical Microbiology 59:4.
Crossref
Linoj Samuel. (2020) Point-of-Care Testing in Microbiology. Clinics in Laboratory Medicine 40:4, pages 483-494.
Crossref
Emilio Guirao Arrabal & María Montes Ruiz-Cabello. (2020) Métodos diagnósticos de la tuberculosis. Medicina Clínica 154:8, pages 305-307.
Crossref
Emilio Guirao Arrabal & María Montes Ruiz-Cabello. (2020) Diagnostic methods of tuberculosis. Medicina Clínica (English Edition) 154:8, pages 305-307.
Crossref
Susrita Sahoo, Satya Narayan Sahu, Subrat kumar Pattanayak, Namrata Misra & Mrutyunjay Suar. 2020. Smart Biosensors in Medical Care. Smart Biosensors in Medical Care 29 47 .
Abdel Naser Dakkah, Yazan Bataineh, Bilal A Al Jaidi, Mohammad F. Bayan & Nabil A. Nimer. 2020. Integrative Nanomedicine for New Therapies. Integrative Nanomedicine for New Therapies 357 404 .
N. Baikunje, D. Behera, A. Rajwanshi, M. Sharma, A. Sharma & K. Sharma. (2019) Comparative evaluation of loop-mediated isothermal amplification (LAMP) assay, GeneXpert MTB/Rif and multiplex PCR for the diagnosis of tubercular lymphadenitis in HIV-infected patients of North India. Molecular and Cellular Probes 48, pages 101459.
Crossref
Akos Somoskovi & Max Salfinger. (2019) How Can the Tuberculosis Laboratory Aid in the Patient-Centered Diagnosis and Management of Tuberculosis?. Clinics in Chest Medicine 40:4, pages 741-753.
Crossref
Sumayya Sumayya, Kharidehal Durga, Nithyananda B. S, Shahvar Fatima & Krishnaiah A. (2019) Study of CBNAAT and Anti-MPT64 Detection in Cytological and Histopathological Material for Early Diagnosis of TB Lymphadenitis. Journal of Evolution of Medical and Dental Sciences 8:47, pages 3540-3544.
Crossref
Bineeta Kashyap, Nisha Goyal, Puneeta Hyanki, NP Singh & Ashwani Khanna. (2019) Cartridge-based nucleic acid amplification test: a novel rapid diagnostic tool to study the burden of tuberculosis from a tertiary care hospital. Tropical Doctor 49:4, pages 274-281.
Crossref
Pallab Kumar Bairagi, Arpit Goyal & Nishith Verma. (2019) Methyl nicotinate biomarker of tuberculosis voltammetrically detected on cobalt nanoparticle-dispersed reduced graphene oxide-based carbon film in blood. Sensors and Actuators B: Chemical 297, pages 126754.
Crossref
Alfred Andama, Akos Somoskovi, Brinnon Mandel, David Bell & Cristina Gutierrez. (2019) Improving diagnosis and case management of patients with tuberculosis: A review of gaps, needs and potential solutions in accessing laboratory diagnostics. Infection, Genetics and Evolution 72, pages 131-140.
Crossref
Xuhui Liu, Lu Xia, Aimei Zhang, Yao Zhang, Yuhong Liu, Shuihua Lu, Yuanlin Song & Shanqun Li. (2019) Increased Diagnostic Yield of Tuberculous Serositis by Using Serous Fluid Drainage Flocky Precipitate (SFDFP) as a Testing Sample. Scientific Reports 9:1.
Crossref
Lilian Akudo Okeke. 2019. Transboundary Animal Diseases in Sahelian Africa and Connected Regions. Transboundary Animal Diseases in Sahelian Africa and Connected Regions 409 422 .
Supriya Sarkar. (2018) Recent Development in the Molecular Diagnosis of Tuberculosis. Bengal Physician Journal 5:2, pages 10-15.
Crossref
Yazmin Berenice Martínez-Martínez, Herminia Guadalupe Martínez-Rodríguez & Salvador Luis Said-Fernández. 2018. Mycobacterium - Research and Development. Mycobacterium - Research and Development.
Kinikanwo Wachukwu Confidence, Paulinus Okwelle Stella, Godwin Nwokah Easter & Amba Ollor Ollor. (2018) Evaluation of gene xpert assay and microscopic examination for detection of Mycobacterium tuberculosis in sputum at Port Harcourt, Nigeria. African Journal of Microbiology Research 12:14, pages 327-332.
Crossref
Natasha Naidoo, Balakrishna Pillay, Martin Bubb, Alexander Pym, Thamsanqa Chiliza, Kogieleum Naidoo, Thumbi Ndung'u, Victoria O. Kasprowicz & Manormoney Pillay. (2018) Evaluation of a synthetic peptide for the detection of anti-Mycobacterium tuberculosis curli pili IgG antibodies in patients with pulmonary tuberculosis. Tuberculosis 109, pages 80-84.
Crossref
M. J. Nasiri, S. Zamani, A. Pormohammad, M. M. Feizabadi, H. R. Aslani, M. Amin, R. Halabian & A. A. Imani Fooladi. (2017) The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran. European Journal of Clinical Microbiology & Infectious Diseases 37:1, pages 9-14.
Crossref
Sergio Mosquera Restrepo, Marta C. Mesa Villanueva & Mauricio Rojas López. (2017) Estrategias alternativas para el diagnóstico de tuberculosis: una opción para los pacientes paucibacilares. Medicina y Laboratorio 23:11-12, pages 513-550.
Crossref
Maxwell Oluwole Akanbi, Chad Achenbach, Babafemi Taiwo, John Idoko, Agatha Ani, Yetunde Isa, Oche Agbaji, Christiana Ukoli, Patrick Akande, Mamoudou Maiga & Robert Leo Murphy. (2017) Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study. BMC Pulmonary Medicine 17:1.
Crossref
Andrea Vergara Gómez, Julià González-Martín & Alberto L. García-Basteiro. (2017) Xpert® MTB/RIF: utilidad en el diagnóstico de la tuberculosis y de la resistencia a la rifampicina. Medicina Clínica 149:9, pages 399-405.
Crossref
Andrea Vergara Gómez, Julià González-Martín & Alberto L. García-Basteiro. (2017) Xpert ® MTB/RIF: Usefulness for the diagnosis of tuberculosis and resistance to rifampicin. Medicina Clínica (English Edition) 149:9, pages 399-405.
Crossref
Subhasis Mukherjee, Debabani Biswas, Shabana Begum, Priyanka Ghosh, Amitava Paul & Supriya Sarkar. (2017) EVALUATION OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST IN DIAGNOSIS OF PULMONARY TUBERCULOSIS. Journal of Evolution of Medical and Dental Sciences 6:74, pages 5281-5286.
Crossref
Tefera Agizew, Rosanna Boyd, Ndwapi Ndwapi, Andrew Auld, Joyce Basotli, Sambayawo Nyirenda, Zegabriel Tedla, Anikie Mathoma, Unami Mathebula, Chawangwa Lesedi, Sherri Pals, Anand Date, Heather Alexander, Thomas Kuebrich & Alyssa Finlay. (2017) Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana. PLOS ONE 12:8, pages e0183237.
Crossref
Tarsizio Chikaonda, Nelson Nguluwe, Brian Barnett, Runa H. Gokhale, Robert Krysiak, Isaac Thengolose, Nora E. Rosenberg, Christopher Stanley, James Mpunga, Irving F. Hoffman, Mina Hosseinipour, Lesley Scott & Wendy Stevens. (2017) Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi. African Journal of Laboratory Medicine 6:2.
Crossref
Kate Clouse, Meridith Blevins, Mary Lou Lindegren, Marcel Yotebieng, Dung Thi Nguyen, Alfred Omondi, Denna Michael, Djimon Marcel Zannou, Gabriela Carriquiry & April Pettit. (2017) Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program. PLOS ONE 12:2, pages e0171384.
Crossref
Kang-Yi Su, Bo-Shiun Yan, Hao-Chieh Chiu, Chong-Jen Yu, So-Yi Chang, Ruwen Jou, Jia-Long Liu, Po-Ren Hsueh & Sung-Liang Yu. (2017) Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS. Scientific Reports 7:1.
Crossref
Aymen Awad Abdelhaleem, Almonther Abdallah Hershan & Pradeep Kumar Agarwal. (2017) Diagnostic Accuracy of IS6110 Insertion Gene, <i>Hsp65</i>, and Xpert MTB/RIF for Rapid Diagnosis of Pulmonary Tuberculosis. Journal of Tuberculosis Research 05:01, pages 1-12.
Crossref
K.-L. Herpoldt, C.N. Loynachan & M.M. Stevens. 2017. Comprehensive Biomaterials II. Comprehensive Biomaterials II 635 656 .
Dwarakanath Srinivas & Pragyan Sarma. 2017. Tuberculosis of the Central Nervous System. Tuberculosis of the Central Nervous System 511 524 .
Swati Jha, Nazir Ismail, David Clark, James J. Lewis, Shaheed Omar, Andries Dreyer, Violet Chihota, Gavin Churchyard & David W. Dowdy. (2016) Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis. PLOS ONE 11:6, pages e0157554.
Crossref
Mulualem Tadesse, Dossegnaw Aragaw, Leen Rigouts & Gemeda Abebe. (2016) Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration. International Journal of Mycobacteriology 5:2, pages 211-218.
Crossref
Luc Bissonnette & Michel Bergeron. (2016) The GenePOC Platform, a Rational Solution for Extreme Point-of-Care Testing. Micromachines 7:6, pages 94.
Crossref
Soma Chakraborty, Arindam Chakraborty, Tathagata Talukder, Mita Mukherjee & Tridip Chatterjee. (2016) Prevalence of <i>Mycobacterium tuberculosis</i> Strains Isolated from Both Pulmonary and Extra Pulmonary Samples and Their Resistance to Rifampicin: A Study from Kolkata and Surrounding Suburbs. Journal of Tuberculosis Research 04:02, pages 61-71.
Crossref
Limakatso Lebina, Nigel Fuller, Tolu Osoba, Lesley Scott, Katlego Motlhaoleng, Modiehi Rakgokong, Pattamukkil Abraham, Ebrahim Variava & Neil Alexander Martinson. (2016) The Use of Xpert MTB/Rif for Active Case Finding among TB Contacts in North West Province, South Africa. Tuberculosis Research and Treatment 2016, pages 1-6.
Crossref
. 2016. Molecular Microbiology. Molecular Microbiology 556 579 .
Prithwiraj De, Anita G. Amin, Eloise Valli, Mark D. Perkins, Michael McNeil & Delphi Chatterjee. (2015) Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine. PLOS ONE 10:12, pages e0144088.
Crossref
Dewald A. Barnard, Elvis M. Irusen, Johannes W. Bruwer, Danté Plekker, Andrew C. Whitelaw, Jacobus D. Deetlefs & Coenraad F. N. Koegelenberg. (2015) The utility of Xpert MTB/RIF performed on bronchial washings obtained in patients with suspected pulmonary tuberculosis in a high prevalence setting. BMC Pulmonary Medicine 15:1.
Crossref
M. M. Z. Matabane, F. Ismail, K. A. Strydom, O. Onwuegbuna, S. V. Omar & N. Ismail. (2015) Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting. BMC Infectious Diseases 15:1.
Crossref
Jeonghyo Kim, Seong Cheol Hong, Jong Chul Hong, Chulhun L. Chang, Tae Jung Park, Hwa-Jung Kim & Jaebeom Lee. (2015) Clinical immunosensing of tuberculosis CFP-10 antigen in urine using interferometric optical fiber array. Sensors and Actuators B: Chemical 216, pages 184-191.
Crossref
Monde Muyoyeta, Maureen Moyo, Nkatya Kasese, Mapopa Ndhlovu, Deborah Milimo, Winfridah Mwanza, Nathan Kapata, Albertus Schaap, Peter Godfrey Faussett & Helen Ayles. (2015) Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings. PLOS ONE 10:6, pages e0126376.
Crossref
Luc Bissonnette & Michel G. Bergeron. 2015. Current and Emerging Technologies for the Diagnosis of Microbial Infections. Current and Emerging Technologies for the Diagnosis of Microbial Infections 87 110 .
Nicola M Zetola, Nenad Macesic, Chawangwa Modongo, Sanghuk Shin, Ronald Ncube & Ronald G Collman. (2014) Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa. BMC Infectious Diseases 14:1.
Crossref
Chaitali Nikam, Mubin Kazi, Chandrasekhar Nair, Majula Jaggannath, Manoj M, Vinaya R, Anjali Shetty & Camilla Rodrigues. (2014) Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis. International Journal of Mycobacteriology 3:3, pages 205-210.
Crossref
John K. Lusiba, Lydia Nakiyingi, Bruce J. Kirenga, Agnes Kiragga, Robert Lukande, Maria Nsereko, Willy Ssengooba, Achilles Katamba, William Worodria, Moses L. Joloba & Harriet Mayanja-Kizza. (2014) Evaluation of Cepheid's Xpert MTB/RIF Test on Pleural Fluid in the Diagnosis of Pleural Tuberculosis in a High Prevalence HIV/TB Setting. PLoS ONE 9:7, pages e102702.
Crossref
Yvonne Linger, Alexander Kukhtin, Julia Golova, Alexander Perov, Amine Lambarqui, Lexi Bryant, George B. Rudy, Kim Dionne, Stefanie L. Fisher, Nicole Parrish & Darrell P. Chandler. (2014) Simplified Microarray System for Simultaneously Detecting Rifampin, Isoniazid, Ethambutol, and Streptomycin Resistance Markers in Mycobacterium tuberculosis. Journal of Clinical Microbiology 52:6, pages 2100-2107.
Crossref
Aubri S. Carman & Arpita G. Patel. (2014) Science with Societal Implications: Detecting Mycobacterium tuberculosis in Africa. Clinical Microbiology Newsletter 36:10, pages 73-77.
Crossref
Yisuo Sun, Shufen Li, Lin Zhou, Lin Zhou, Qiu Zhong, Shisong Fang, Tao Chen, Lijun Bi, Wai-Kin Mat, Cunyou Zhao & Hong Xue. (2014) A rapid fluorescence polarization-based method for genotypic detection of drug resistance in Mycobacterium tuberculosis. Applied Microbiology and Biotechnology 98:9, pages 4095-4105.
Crossref
Leonardo Bruno Paz Ferreira Barreto, Maria Cristina da Silva Lourenço, Valéria Cavalcanti Rolla, Valdiléia Gonçalves Veloso & Gisele Huf. (2014) Use of amplified Mycobacterium tuberculosis direct test in respiratory samples from HIV-infected patients in Brazil. Jornal Brasileiro de Pneumologia 40:2, pages 148-154.
Crossref
Liat Rosenfeld, Yunfeng Cheng, Jianghong Rao & Sindy K. Y. Tang. Rapid detection of tuberculosis using droplet-based microfluidics. Rapid detection of tuberculosis using droplet-based microfluidics.
Karen R Steingart, Ian Schiller, David J Horne, Madhukar Pai, Catharina C Boehme & Nandini Dendukuri. (2014) Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews.
Crossref
Haider Abdulrazzaq Abed Al-Darraji, Humaira Abd Razak, Kee Peng Ng, Frederick L. Altice & Adeeba Kamarulzaman. (2013) The Diagnostic Performance of a Single GeneXpert MTB/RIF Assay in an Intensified Tuberculosis Case Finding Survey among HIV-Infected Prisoners in Malaysia. PLoS ONE 8:9, pages e73717.
Crossref
Yu Pang, Qiang Li, Xichao Ou, Hojoon Sohn, Zhiying Zhang, Junchen Li, Hui Xia, Kai Man Kam, Richard J. O’Brien, Junying Chi, Shitong Huan, Daniel P. Chin & Yan-lin Zhao. (2013) Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China. PLoS ONE 8:7, pages e69267.
Crossref
ShuQi Wang, Fatih Inci, Gennaro De Libero, Amit Singhal & Utkan Demirci. (2013) Point-of-care assays for tuberculosis: Role of nanotechnology/microfluidics. Biotechnology Advances 31:4, pages 438-449.
Crossref
Yu Pang, Hui Xia, Zhiying Zhang, Junchen Li, Yi Dong, Qiang Li, Xichao Ou, Yuanyuan Song, Yufeng Wang, Richard O'Brien, Kai Man Kam, Junying Chi, Shitong Huan, Daniel P. Chin & Yanlin Zhao. (2013) Multicenter Evaluation of Genechip for Detection of Multidrug-Resistant Mycobacterium tuberculosis. Journal of Clinical Microbiology 51:6, pages 1707-1713.
Crossref
Jennifer Ho, Ben J. Marais, Gwendolyn L. Gilbert & Anna P. Ralph. (2013) Diagnosing tuberculous meningitis - have we made any progress?. Tropical Medicine & International Health 18:6, pages 783-793.
Crossref
Margaret L. McNairy, Myron Cohen & Wafaa M. El-Sadr. (2013) Antiretroviral Therapy for Prevention Is a Combination Strategy. Current HIV/AIDS Reports 10:2, pages 152-158.
Crossref
Charlotte A. Gaydos. (2013) What Is the Role of Newer Molecular Tests in the Management of CAP?. Infectious Disease Clinics of North America 27:1, pages 49-69.
Crossref
Afrânio Kritski, Paula I. Fujiwara, Maria Armanda Vieira, Antonio Ruffino Netto, Martha Maria Oliveira, Gisele Huf & S. Bertel Squire. (2013) Assessing new strategies for TB diagnosis in low- and middle-income countries. The Brazilian Journal of Infectious Diseases 17:2, pages 211-217.
Crossref
Karen R Steingart, Hojoon Sohn, Ian Schiller, Lorie A Kloda, Catharina C Boehme, Madhukar Pai & Nandini Dendukuri. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Natalie V. S. Vinkeles Melchers, Sabine L. van Elsland, Joep M. A. Lange, Martien W. Borgdorff & Jan van den Hombergh. (2013) State of Affairs of Tuberculosis in Prison Facilities: A Systematic Review of Screening Practices and Recommendations for Best TB Control. PLoS ONE 8:1, pages e53644.
Crossref
Domingo PalmeroViviana Ritacco. (2013) Clinical Management of Drug-Resistant Tuberculosis in Resource Constrained Settings. Clinical Medicine Insights: Therapeutics 5, pages CMT.S6560.
Crossref
Haochen Cui, Shanshan Li, Quan Yuan, Ashutosh Wadhwa, Shigetoshi Eda, Mark Chambers, Roland Ashford, Hongyuan Jiang & Jie Wu. (2013) An AC electrokinetic impedance immunosensor for rapid detection of tuberculosis. The Analyst 138:23, pages 7188.
Crossref
Abdullah Kilic. 2013. Advanced Techniques in Diagnostic Microbiology. Advanced Techniques in Diagnostic Microbiology 557 586 .
J. O'Grady, M. Bates, L. Chilukutu, J. Mzyece, B. Cheelo, M. Chilufya, L. Mukonda, M. Mumba, J. Tembo, M. Chomba, N. Kapata, M. Maeurer, A. Rachow, P. Clowes, M. Hoelscher, P. Mwaba & A. Zumla. (2012) Evaluation of the Xpert MTB/RIF Assay at a Tertiary Care Referral Hospital in a Setting Where Tuberculosis and HIV Infection Are Highly Endemic. Clinical Infectious Diseases 55:9, pages 1171-1178.
Crossref
Kathryn Schnippel, Gesine Meyer‐Rath, Lawrence Long, William MacLeod, Ian Sanne, Wendy S. Stevens & Sydney Rosen. (2012) Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ vs. clinic‐based roll‐out in South Africa . Tropical Medicine & International Health 17:9, pages 1142-1151.
Crossref
Robert H. Gilman, Daniela E. Kirwan & María Kathia Cárdenas. (2012) Rapid Implementation of New TB Diagnostic Tests: Is It Too Soon for a Global Roll-Out of Xpert MTB/RIF?. The American Journal of Tropical Medicine and Hygiene 87:2, pages 197-201.
Crossref
Kai Chang, Weiping Lu, Junji Wang, Kejun Zhang, Shuangrong Jia, Fake Li, Shaoli Deng & Ming Chen. (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A meta-analysis. Journal of Infection 64:6, pages 580-588.
Crossref
Ruth McNerney, Markus Maeurer, Ibrahim Abubakar, Ben Marais, Timothy D. Mchugh, Nathan Ford, Karin Weyer, Steve Lawn, Martin P. Grobusch, Ziad Memish, S. Bertel Squire, Giuseppe Pantaleo, Jeremiah Chakaya, Martina Casenghi, Giovanni-Batista Migliori, Peter Mwaba, Lynn Zijenah, Michael Hoelscher, Helen Cox, Soumya Swaminathan, Peter S. Kim, Marco Schito, Alexandre Harari, Matthew Bates, Samana Schwank, Justin O’Grady, Michel Pletschette, Lucica Ditui, Rifat Atun & Alimuddin Zumla. (2012) Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities. The Journal of Infectious Diseases 205:suppl_2, pages S147-S158.
Crossref
Luc Bissonnette & Michel G. Bergeron. (2012) Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies. Journal of Personalized Medicine 2:2, pages 50-70.
Crossref
C. Martin & J. Maugein. (2012) Bactériologie des mycobactéries responsables d’infections respiratoires. EMC - Pneumologie 9:2, pages 1-15.
Crossref
Gisele Huf & Afrânio Kritski. (2012) Avaliação da utilidade clínica de novos testes diagnósticos em tuberculose: o papel dos ensaios clínicos pragmáticos. Jornal Brasileiro de Pneumologia 38:2, pages 237-245.
Crossref
Paras Jain, Travis E. Hartman, Nell Eisenberg, Max R. O'Donnell, Jordan Kriakov, Karnishree Govender, Mantha Makume, David S. Thaler, Graham F. Hatfull, A. Willem Sturm, Michelle H. Larsen, Preshnie Moodley & William R. JacobsJr.Jr.. (2012) ϕ 2 GFP10, a High-Intensity Fluorophage, Enables Detection and Rapid Drug Susceptibility Testing of Mycobacterium tuberculosis Directly from Sputum Samples . Journal of Clinical Microbiology 50:4, pages 1362-1369.
Crossref
Sophia B. Georghiou, Marisa Magana, Richard S. Garfein, Donald G. Catanzaro, Antonino Catanzaro & Timothy C. Rodwell. (2012) Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review. PLoS ONE 7:3, pages e33275.
Crossref
Roberto Zenteno-CuevasBetzaida Cuevas-CordobaAntonio EncisoLeonor EncisoAremy Cuellar. (2012) Assessing the utility of three TaqMan probes for the diagnosis of tuberculosis and resistance to rifampin and isoniazid in Veracruz, México. Canadian Journal of Microbiology 58:3, pages 318-325.
Crossref
Hojoon Sohn, Madhukar Pai, Nandini Dendukuri, Lorie A Kloda, Catharina C Boehme & Karen R Steingart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Ashutosh Wadhwa, Graham J. Hickling & Shigetoshi Eda. (2012) Opportunities for Improved Serodiagnosis of Human Tuberculosis, Bovine Tuberculosis, and Paratuberculosis. Veterinary Medicine International 2012, pages 1-13.
Crossref
L. E. Scott, N. Gous, B. E. Cunningham, B. D. Kana, O. Perovic, L. Erasmus, G. J. Coetzee, H. Koornhof & W. Stevens. (2011) Dried Culture Spots for Xpert MTB/RIF External Quality Assessment: Results of a Phase 1 Pilot Study in South Africa. Journal of Clinical Microbiology 49:12, pages 4356-4360.
Crossref
M. Bonnet. (2011) Les nouveaux tests diagnostiques de la tuberculose maladie : de la théorie à la pratique dans les pays du Sud. Revue des Maladies Respiratoires 28:10, pages 1310-1321.
Crossref
Paras Jain, David S. Thaler, Mamoudou Maiga, Graham S. Timmins, William R. Bishai, Graham F. Hatfull, Michelle H. Larsen & William R. Jacobs. (2011) Reporter Phage and Breath Tests: Emerging Phenotypic Assays for Diagnosing Active Tuberculosis, Antibiotic Resistance, and Treatment Efficacy. The Journal of Infectious Diseases 204:suppl_4, pages S1142-S1150.
Crossref
Karin Weyer, Susanne Carai & Paul Nunn. (2011) Viewpoint TB Diagnostics: What Does the World Really Need?. The Journal of Infectious Diseases 204:suppl_4, pages S1196-S1202.
Crossref
Michaela Projahn, Claudio U. Köser, Susanne Homolka, David K. Summers, John A. C. Archer & Stefan Niemann. (2011) Polymorphisms in Isoniazid and Prothionamide Resistance Genes of the Mycobacterium tuberculosis Complex. Antimicrobial Agents and Chemotherapy 55:9, pages 4408-4411.
Crossref
Panayotis Ioannidis, Dimitrios Papaventsis, Simona Karabela, Stavroula Nikolaou, Marina Panagi, Ekaterini Raftopoulou, Eythymia Konstantinidou, Ioanna Marinou & Sofia Kanavaki. (2011) Cepheid GeneXpert MTB/RIF Assay for Mycobacterium tuberculosis Detection and Rifampin Resistance Identification in Patients with Substantial Clinical Indications of Tuberculosis and Smear-Negative Microscopy Results. Journal of Clinical Microbiology 49:8, pages 3068-3070.
Crossref
Carlton A. Evans. (2011) GeneXpert—A Game-Changer for Tuberculosis Control?. PLoS Medicine 8:7, pages e1001064.
Crossref
Grant Theron, Jonny Peter, Richard van Zyl-Smit, Hridesh Mishra, Elizabeth Streicher, Samuel Murray, Rodney Dawson, Andrew Whitelaw, Michael Hoelscher, Surendra Sharma, Madhukar Pai, Robin Warren & Keertan Dheda. (2011) Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting. American Journal of Respiratory and Critical Care Medicine 184:1, pages 132-140.
Crossref
Peter Mwaba, Ruth McNerney, Martin Peter Grobusch, Justin O’Grady, Matthew Bates, Nathan Kapata, Markus Maeurer & Alimuddin Zumla. (2011) Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis. Tropical Medicine & International Health 16:7, pages 819-827.
Crossref
Justin OʼGrady, Markus Maeurer, Peter Mwaba, Nathan Kapata, Matthew Bates, Michael Hoelscher & Alimuddin Zumla. (2011) New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Current Opinion in Pulmonary Medicine 17:3, pages 134-141.
Crossref
Christine C. Ginocchio. (2011) Strengths and Weaknesses of FDA-Approved/Cleared Diagnostic Devices for the Molecular Detection of Respiratory Pathogens. Clinical Infectious Diseases 52:suppl_4, pages S312-S325.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.